Genzyme, Cobrek End Kidney Drug Patent Fight
Genzyme will dismiss its claims against Cobrek without prejudice, while Cobrek will dismiss its counterclaims against Genzyme with prejudice, according to a joint stipulation of dismissal filed in the Northern District of Illinois.
The parties couldn't immediately be reached for comment Friday.
The dispute dates back to...
To view the full article, register now.